European Archives - Page 1159 of 1393 - European Medical Journal

This site is intended for healthcare professionals

Continue
24 Oct 2017

Introducing EMJ Oncology 5.1

United Kingdom, October 24, 2017: Welcome to this year’s issue of EMJ Oncology, which is filled with the latest developments from the world of cancer…
1 Mins
24 Oct 2017

Dexamethasone Contributes to the Side Effects in Glioblastoma Treatment

Glioblastoma (GBM) is the most common and malignant primary brain tumour and is characterised by the active invasion of tumour cells into surrounding…
October 2017

EMJ Oncology 5.1 2017

Welcome to this year’s issue of EMJ Oncology, which is filled with the latest developments from the world of cancer studies.
17 Mins
24 Oct 2017

Review of the European Society of Medical Oncology Congress 2017

After a 3-year period, the historic Spanish capital, Madrid, once again welcomed the European Society for Medical Oncology (ESMO) annual meeting, from the…
2 Mins
24 Oct 2017

Experience in Managing Patients with Carcinoid Syndrome from A European Neuroendocrine Tumour Society Centre Of Excellence

Carcinoid syndrome is a combination of signs and symptoms, such as skin flushing, diarrhoea, bronchospasm, and fibrotic valvulopathy, resulting from…
9 Mins
24 Oct 2017

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer

Pancreatic cancer (PC) still represents an unresolved therapeutic challenge due to the associated poor prognosis and the lack of responsiveness to…
2 Mins
24 Oct 2017

Cancer Patient Attitudes and Preferences Toward Smoking Status Assessment

Tobacco smoking affects the development, treatment response, prognosis, and recurrence of a variety of cancers.
9 Mins
24 Oct 2017

Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria

Radical prostatectomy is widely used as the primary modality of treatment for clinically localised prostate cancer.
2 Mins
24 Oct 2017

Random Optimisation Interactive System Based on Kernel Learning (Risk) for Venous Thromboembolism Risk Assessment in Chemotherapy-Treated Cancer Patients

Venous thromboembolism (VTE) risk assessment is a major challenge in cancer outpatients treated with chemotherapy, as its development may result in…
9 Mins
24 Oct 2017

Prognostic and Predictive Value of FDG-PET as an Aid in Oesophageal Cancer Management

FDG-PET is widely used for cancer staging before treatment and detection of recurrence during post-treatment surveillance.
We’ve noticed you’re accessing
from North/South America.